Clinical trial
Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral…
NCT00002673 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00002673 |
|---|---|
| Title | Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation |
| Official title | A PHASE II STUDY OF CELLULAR ADOPTIVE IMMUNOTHERAPY AS PROPHYLAXIS FOR CYTOMEGALOVIRUS DISEASE AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Procedure |
| Interventions | infection prophylaxis and management |
| Enrollment | 30 |
| Start date | Jun 1, 1995 |
| Completion | Feb 1, 2002 |
| First posted | May 21, 2004 |
| Last update posted | Jun 17, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: